Skip to content
Doctor examining mole on back of woman

This content provides you with information to help you better understand the signs, symptoms, risk factors, detection techniques, treatment choices, and post-treatment support linked to Melanoma.  

We hope this content provided education and guidance. Remember to stay informed, make educated choices early, and speak to your health care team about any concerns. Also, you don’t have to face these challenges alone. Seek support from friends, family, support groups, and mental health professionals to navigate this journey.


1. Centeno PP, Pavet V, Marais R. The journey from melanocytes to melanoma. Nat Rev Cancer. 2023;23(6):372-390. doi:10.1038/s41568-023-00565-7

2. Saginala K, Barsouk A, Sukumar Aluru J, Rawla P, Barsouk A. Epidemiology of Melanoma. Med Sci. 2021;9(63). doi:10.3390/medsci9040063

3. Teixido C, Castillo P, Martinez-Vila C, Arance A, Alos L. Molecular markers and targets in melanoma. Cells. 2021;10(9):1-31. doi:10.3390/cells10092320

4. Agar N, Young AR. Melanogenesis: A photoprotective response to DNA damage? Mutat Res – Fundam Mol Mech Mutagen. 2005;571(1-2 SPEC. ISS.):121-132. doi:10.1016/j.mrfmmm.2004.11.016

5. Schadendorf D, van Akkooi ACJ, Berking C, et al. Melanoma. Lancet. 2018;392(10151):971-984. doi:10.1016/S0140-6736(18)31559-9

6. Gupta AK, Bharadwaj M, Mehrotra R. Skin Cancer Concerns in People of Color: Risk Factors and Prevention. Asian Pacific J Cancer Prev. 2016;17(12):5257-5264. doi:10.22034/APJCP.2016.17.12.5257

7. Saw RPM, Bartula I, Winstanley JB, et al. Melanoma and Quality of Life. Handb Qual Life Cancer. Published online 2022:439-466. doi:10.1007/978-3-030-84702-9_26

8. Danielsen JT, Strøm L, Knutzen SM, et al. Psychological and behavioral symptoms in patients with melanoma: A systematic review and meta‐analysis. Psychooncology. 2023;(June):1208-1222. doi:10.1002/pon.6184

9. Rauwerdink DJW, van Doorn R, van der Hage J, et al. Systemic Therapy in Advanced Nodular Melanoma versus Superficial Spreading Melanoma: A Nation-Wide Study of the Dutch Melanoma Treatment Registry. Cancers (Basel). 2022;14(22). doi:10.3390/cancers14225694

10. Singh P, Kim HJ, Schwartz RA. Superficial spreading melanoma: An analysis of 97,702 cases using the SEER database. Melanoma Res. 2016;26(4):395-400. doi:10.1097/CMR.0000000000000245

11. Menzies SW, Moloney FJ, Byth K, et al. Dermoscopic evaluation of nodular melanoma. JAMA Dermatology. 2013;149(6):699-709. doi:10.1001/jamadermatol.2013.2466

12. McKenna JK, Florell SR, Goldman GD, Bowen GM. Lentigo maligna/lentigo maligna melanoma: Current state of diagnosis and treatment. Dermatologic Surg. 2006;32(4):493-504. doi:10.1111/j.1524-4725.2006.32102.x

13. Goydos JS, Shoen SL. Acral lentiginous melanoma. Cancer Treat Res. 2016;167:321-329. doi:10.1007/978-3-319-22539-5_14

14. Rabbie R, Ferguson P, Molina-Aguilar C, Adams DJ, Robles-Espinoza CD. Melanoma subtypes: genomic profiles, prognostic molecular markers and therapeutic possibilities. J Pathol. 2019;247(5):539-551. doi:10.1002/path.5213

15. Dessinioti C, Antoniou C, Katsambas A, Stratigos AJ. Melanocortin 1 receptor variants: Functional role and pigmentary associations. Photochem Photobiol. 2011;87(5):978-987. doi:10.1111/j.1751-1097.2011.00970.x

16. Rossi M, Pellegrini C, Cardelli L, Ciciarelli V, Nardo L Di, Fargnoli MC. Familial Melanoma: Diagnostic and Management Implications. Dermatol Pr Concept. 2019;9(1):10-16.

17. Davis LE, Shalin SC, Tackett AJ. Current state of melanoma diagnosis and treatment. Cancer Biol Ther. 2019;20(11):1366-1379. doi:10.1080/15384047.2019.1640032

18. Matthews NH, Li W-Q, Qureshi AA, Weinstock MA, Cho E. Epidemiology of Melanoma. Melanoma Clin Pract. Published online 2021:31-45. doi:10.1007/978-3-030-82639-0_2

19. Killeen T, Shanley R, Ramesh V, Giubellino A. Malignant melanoma in immunocompromised patients: A statistical and pathologic analysis. Lab Investig. 2021;101(SUPPL:301.

20. Narayanan DL, Saladi RN, Fox JL. Ultraviolet radiation and skin cancer. Int J Dermatol. 2010;49(9):978-986. doi:10.1111/j.1365-4632.2010.04474.x

21. Del Marmol V. Prevention and screening of melanoma in Europe: 20 years of the Euromelanoma campaign. J Eur Acad Dermatology Venereol. 2022;36(S6):5-11. doi:10.1111/jdv.18195

22. Matsumoto M, Wack S, Weinstock MA, et al. Five-Year Outcomes of a Melanoma Screening Initiative in a Large Health Care System. JAMA Dermatology. 2022;158(5):504-512. doi:10.1001/jamadermatol.2022.0253

23. Young AT, Vora NB, Cortez J, et al. The role of technology in melanoma screening and diagnosis. Pigment Cell Melanoma Res. 2021;34(2):288-300. doi:10.1111/pcmr.12907

24. Holder WD, White RL, Zuger JH, Easton EJ, Greene FL. Effectiveness of positron emission tomography for the detection of melanoma metastases. Ann Surg. 1998;227(5):764-771. doi:10.1097/00000658-199805000-00017

25. Surasi DS, Bhambhvani P, Baldwin JA, Almodovar SE, O’Malley JP. 18F-FDG PET and PET/CT patient preparation: A review of the literature. J Nucl Med Technol. 2014;42(1):5-13. doi:10.2967/jnmt.113.132621

26. Bisschop C, de Heer EC, Brouwers AH, Hospers GAP, Jalving M. Rational use of 18F-FDG PET/CT in patients with advanced cutaneous melanoma: A systematic review. Crit Rev Oncol Hematol. 2020;153(June):103044. doi:10.1016/j.critrevonc.2020.103044

27. Scolyer RA, Rawson R V., Gershenwald JE, Ferguson PM, Prieto VG. Melanoma pathology reporting and staging. Mod Pathol. 2020;33:15-24. doi:10.1038/s41379-019-0402-x

28. Rodriguez Rivera AM, Alabbas H, Ramjaun A, Meguerditchian AN. Value of positron emission tomography scan in stage III cutaneous melanoma: A systematic review and meta-analysis. Surg Oncol. 2014;23(1):11-16. doi:10.1016/j.suronc.2014.01.002

29. Curti BD, Faries MB. Recent advances in the treatment of melanoma. N Engl J Med. 2021;384:2229–2240. doi:10.1056/nejmra2034861

30. Michielin O, Van Akkooi ACJ, Ascierto PA, Dummer R, Keilholz U. Cutaneous melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2019;30(12):1884-1901. doi:10.1093/annonc/mdz411

31. Scally CP, Wong SL. Intensity of follow-up after melanoma surgery. Ann Surg Oncol. 2014;21(3):752-757. doi:10.1245/s10434-013-3295-9